English 日本語 Contact Us Sitemap
Animals Diets Tools Services About Us Home
Home > About Us
Physiogenex (France) collaboration
         - Diabetic Retinopathy
About CLEA Japan, Inc.
CLEA Japan has a collaboration project of Diabetic Nephropathy model development with Physiogenex, a French preclinical CRO with expertise in obesity/type 2 diabetes and related complications.

As the same time, Physiogenex, Iris Pharma and CLEA Japan Inc., have also developed and validated the SDT fatty rat for evaluating drugs targeting diabetic retinopathy through our partnership.
Presentation Record  (↓Decending order)
Poster Presentation   ARVO 2018 - May 1st, 2018

Poster Title:
The Uni-Nephrectomized SDT Fatty Rat, a novel Type 2 diabetic model of Diabetic Nephropathy, develops features of diabetic retinopathy over 10 weeks

Uni-nephrectomized SDT fatty rats develop features of diabetic retinopathy in parallel with diabetic nephropathy. Our original data set suggests that this rat model is suitable to evaluate the effects of drugs on these type 2 diabetes co-morbidities.

← Click here to download the Poster PDF

Animals Diets Tools Services About Us Importing Animals Home

Copyright © 1999-2012 CLEA Japan,Inc. All right reserved.